Skip to main content
Evidence Based Longevity (EBL)Check what I take
← All protocols
C

Protocol

Speed-of-processing cognitive training for dementia prevention

In the ACTIVE trial, healthy older adults given 10 to 18 sessions of computerized speed-of-processing training had a lower risk of dementia over 10 years than controls (HR 0.71), with a confidence interval The range the true effect probably falls in. A wide interval means the estimate is uncertain. ending at 0.998.

Grade C: human trials exist, but they are small, mixed or not yet repeated. This is not a finding that it does not work. How to read a grade →

Compare this record with another, side by side →

At a glance

In plain words

In a large US trial, healthy older adults practiced a computer task that trains how fast they take in what they see. Ten years later, those who did this training were less likely to have developed dementia. Memory and reasoning training did not show this. The dementia finding came from a later look at the trial, and only one trial has shown it.

The letter, taken apart
What was measured
New dementia diagnoses over 10 years.
How big
Dementia was less likely: 0.71 times the rate of people without training.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 29201994.
Who it applies to
Healthy adults aged 65 or older at the start.
Safety
None identified.
The record in one view
Compared with
No training.
Certainty
Grade C, resting on: One randomized trial, with a later dementia analysis.
What would change this grade
Could rise to B with: Randomized trial of speed-of-processing training. Who: Healthy older adults. Measured: Dementia incidence as the primary outcome. Length: At least 5 years.
Cost
No price recorded yet.
Sources
2 studies cited on this record, listed under Sources.
For clinicians
A one-page summary of this record that prints with a clinician's name and practice, folds to a plain-language patient handout, and gives a chart note to paste into the patient record: Printable summary and chart note.
CHard clinical endpoint Grade C

In the ACTIVE trial, healthy older adults given 10 to 18 sessions of computerized speed-of-processing training had a lower risk of dementia over 10 years than controls (HR 0.71), with a confidence interval ending at 0.998. Memory and reasoning training did not lower it. The dementia result comes from a later analysis of the trial.

Why this letter

Why this gradeGrade C, small or unreplicated trials. The reasoning, and what the grade does not cover.
Why this grade

Grade C on dementia. In the ACTIVE trial, speed-of-processing training lowered 10-year dementia risk with a confidence interval just excluding no effect (Edwards et al., 2017; PMID 29201994).

WHY NOT Bone trial, the dementia result is a later analysis rather than the trial's primary outcome, and the other two training types did not show it.

WHAT THIS GRADE DOES NOT COVERcommercial brain-training games in general, and memory or reasoning training. It also does not cover people who already have memory problems, who were excluded at the start.

A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →

Who responds: this record's trial reading reports no subgroup that identifies who responds.

Evidence notes: randomized trial

Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded: Dementia diagnosis (hard)

Last reviewed: November 2026

Evidence wanted

The trial that would change this grade.

DesignRandomized trial of speed-of-processing training
PopulationHealthy older adults
EndpointDementia incidence as the primary outcome
DurationAt least 5 years

A positive trial of this shape, supported by further trials, would move this entry to B.

Why the current trials fall short

A trial with dementia as its primary outcome would carry it to B.

Clinical trials

ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Cognitive Training among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.

Search recruiting studies of Cognitive Training on ClinicalTrials.gov

Dose, form and timing

What to track

Not applicable; the outcome is dementia.

Safety

Safety evidence, by strength

No safety data. Each caution on this record, sorted by what it rests on.

Documented in human studies
Cautions resting on what randomized trials or large studies found in people.

None recorded.

Suspected from case reports
Harms reported in individual patients or uncontrolled observations, not confirmed by a trial.

None recorded.

Mechanistic only
Cautions reasoned from how it works, with no human harm data behind them.

None recorded.

Population cautions
Groups in whom it has not been studied, so its safety there is unknown.

None recorded.

No safety data

No safety data: EBL has found no trial or report of harm for this record. That is an absence of evidence, not a finding of safety.

Grade history

How this letter has changedLatest: No. 468 · November 2026 · First graded.
Grade history
No. 468 · November 2026 · First graded
Speed-of-processing cognitive training for dementia prevention is added from the gap report: Grade C

New record in the gap-report batch. In the ACTIVE trial, healthy older adults given 10 to 18 sessions of computerized speed-of-processing training had a lower risk of dementia over 10 years than controls (HR 0.71), with a confidence interval ending at 0.998. Memory and reasoning training did not lower it. The dementia result comes from a later analysis of the trial.PMID 29201994 PMID 24417410

Every change to a letter on this site is dated and published. The full evidence log →

Sources

How this record was checked
Citations
Every paper cited on this page is matched to its PubMed record on every build.
Retractions
None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
Read against the papers
November 2026. By a language model (AI-assisted reading), not yet reviewed by a clinician.
Outside review
Not yet done. No reviewer outside EBL has checked this record.

What each of these checks can and cannot show: evidence integrity.

The evidence, in fullTwo papers, each linked to its PubMed record.
The evidence

Edwards et al. (Alzheimers Dement (N Y), 2017; PMID 29201994): ACTIVE trial, 2,802 healthy older adults, 10-year follow-up; 260 dementia cases; speed training HR 0.71 (95% CI 0.50 to 0.998) against control; memory and reasoning training not significant. Rebok et al. (J Am Geriatr Soc, 2014; PMID 24417410): 10-year results; all three trainings reduced self-reported difficulty with daily activities.

How EBL searched for the trials (1 search)

The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.

Searched PubMed in November 2026. 8 records screened, 2 eligible for the graded claim.
Query: ("speed of processing"[tiab] OR "cognitive training"[tiab]) AND dementia[tiab] AND randomized controlled trial[pt]
The 8 most recent of 191 records were screened by title; none is a trial with dementia incidence as its outcome.
PubMed watch: does a new study change the grade? (nothing new)

No new paper matching the search behind this grade has been added to PubMed since November 2026.

Last run November 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.

Who paid for these trials

For each trial behind a letter on this page, the funding its PubMed record lists. "No funder" means PubMed lists none, not that the trial had no funding.

  • Rebok et al., 2014, J Am Geriatr Soc (PMID 24417410): PubMed lists funding from US National Institutes of Health (National Institute on Aging); US National Institutes of Health (National Institute of Nursing Research); US National Institutes of Health (National Institute of Child Health and Human Development).

Disclosure

Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.

Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy

© Evidence Based Longevity, Inc. All rights reserved

Medical disclaimer

These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.

Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →

Build 9b19d78, November 2026